---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-23-028397"
form_type: "8-K"
ticker: "NUWE"
cik: "0001506492"
company_name: "Nuwellis, Inc."
filed_at: "2023-06-05T23:59:59+00:00"
generated_at: "2026-06-14T07:18:31.501735+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Nuwellis appoints Michael McCormick to board as Lead Independent Director; Warren Watson resigns

## Summary
- McCormick appointed Class I director effective June 1, 2023, as Lead Independent Director, Audit Committee member, and Nominating Committee Chair.
- McCormick receives $45K annual retainer plus $10K Lead Director fee, $7.5K Audit Committee, $10K Nominating Chair.
- Warren Watson resigned June 2, 2023, from board and all committees; no disagreement with company.
- McCormick has 25+ years med device experience, formerly CEO of Osprey Medical and Anulex Technologies.

## SEC filing metadata
- accession: 0001140361-23-028397
- form_type: 8-K
- ticker: NUWE
- cik: 0001506492
- company_name: Nuwellis, Inc.
- filed_at: 2023-06-05T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1506492/000114036123028397/0001140361-23-028397-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1506492/000114036123028397/brhc20054036_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-23-028397
- JSON: https://secwatch.observer/filing/0001140361-23-028397.json
- Plain text: https://secwatch.observer/filing/0001140361-23-028397.txt

## Key facts
- Executive change
  Michael McCormick was appointed as Lead Independent Director at Nuwellis, Inc..
  - Action: appointed
  - Role: Lead Independent Director
  source text: On May 30, 2023, the Board of Directors (the " Board ") of Nuwellis, Inc., a Delaware corporation (the " Company ") approved, effective as of June 1, 2023, the appointment of Michael McCormick to fill a vacancy in the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1506492/000114036123028397/0001140361-23-028397-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.